TP53 and neoplasm: Differences in tumor genomics by race have also been observed, such as higher rates of TMPRSS2:ERG gene fusions in European American men compared to non-European American men [3] and differing mutation rates of driver genes such as TP53, AR, and CDK12 [1, 4].